<p class=”eplus-wrapper”><a href=”https://channel.royalcast.com/landingpage/transgene/20230316_1/”>lien</a></p>
Category: Webcast
Transgene R&D Day (Paris, France)
Lien
2022 Half-year results and business update
link to webcast lien
License Option Exercise by AstraZeneca for an Oncolytic Virus Generated by Invir.IO™ Platform
License Option Exercise by AstraZeneca
TG4050, First positive clinical data from Phase I clinical trials
link to webcast
Half-Year results 2021 & Business Update
lien
2021 Full-year results and business update
link to webcast
Full Year Results 2020, Business Update & Update on the clinical development plan of TG4001 (in French)
Link to the webcast
Full Year Results 2020, Business Update & Update on the clinical development plan of TG4001
Link to the webcast
Detailed results of the Phase 1b/2 trial of TG4001 and avelumab in advanced HPV-positive cancers presented at SITC 2020
Link to webcast
